CDK2 and lung carcinoma: Synthetic molecules like dihydroartemisinin have targeted AKT/GSK3β/cyclinD1 to induce apoptosis in lung cancer cell lines48 and cediranib arrested cell cycle and induced apoptosis via CDK4/cyclin D1 and CDK2/cyclin E49.